Accelerate Diagnostics Stock Cash Flow From Operations
| AXDXDelisted Stock | USD 0.04 0.02 164.90% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Accelerate Diagnostics' long-term financial health and intrinsic value.
Accelerate |
Accelerate Diagnostics Company Cash Flow From Operations Analysis
Accelerate Diagnostics' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Accelerate Diagnostics Cash Flow From Operations | (24.19 M) |
Most of Accelerate Diagnostics' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Accelerate Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
CompetitionIn accordance with the recently published financial statements, Accelerate Diagnostics has (24.19 Million) in Cash Flow From Operations. This is 104.59% lower than that of the Health Care Equipment & Supplies sector and 106.62% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 102.49% higher than that of the company.
Accelerate Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Accelerate Diagnostics' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Accelerate Diagnostics could also be used in its relative valuation, which is a method of valuing Accelerate Diagnostics by comparing valuation metrics of similar companies.Accelerate Diagnostics is currently under evaluation in cash flow from operations category among its peers.
Accelerate Fundamentals
| Return On Asset | -0.74 | |||
| Operating Margin | (2.82) % | |||
| Current Valuation | 50.42 M | |||
| Shares Outstanding | 25.29 M | |||
| Shares Owned By Insiders | 38.30 % | |||
| Shares Owned By Institutions | 17.91 % | |||
| Number Of Shares Shorted | 297.38 K | |||
| Price To Earning | (15.18) X | |||
| Price To Sales | 0.07 X | |||
| Revenue | 11.7 M | |||
| Gross Profit | 2.7 M | |||
| EBITDA | (33.57 M) | |||
| Net Income | (50.05 M) | |||
| Cash And Equivalents | 36.77 M | |||
| Cash Per Share | 0.45 X | |||
| Total Debt | 66.58 M | |||
| Debt To Equity | 2.76 % | |||
| Current Ratio | 4.48 X | |||
| Book Value Per Share | (2.23) X | |||
| Cash Flow From Operations | (24.19 M) | |||
| Short Ratio | 6.15 X | |||
| Earnings Per Share | (2.15) X | |||
| Price To Earnings To Growth | (0.55) X | |||
| Target Price | 1.5 | |||
| Number Of Employees | 107 | |||
| Beta | 0.22 | |||
| Market Capitalization | 859.92 K | |||
| Total Asset | 28.56 M | |||
| Retained Earnings | (718.9 M) | |||
| Working Capital | (8.96 M) | |||
| Current Asset | 91.68 M | |||
| Current Liabilities | 4.45 M | |||
| Net Asset | 28.56 M |
About Accelerate Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Accelerate Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Accelerate Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Accelerate Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Accelerate Stock
If you are still planning to invest in Accelerate Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accelerate Diagnostics' history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |